Medicines Control Agency

Medicines Control Agency Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Medicines Control Agency, Public & Government Service, Off OIC Harding Highway Sukuta West Coast Region The Gambia, P. O. Box 3162, Sukuta.

The Mandate of Medicines Control Agency (MCA)
The Medicines and Related Products Act 2014, established the Medicines Control Agency with the mandate to control the manufacture, importation, exportation, distribution, use and advertisements of Medicines

GCP Inspection in Basse The Directorate of Clinical Trials and Pharmacovigilance at the Medicines Control Agency (MCA) c...
28/08/2026

GCP Inspection in Basse

The Directorate of Clinical Trials and Pharmacovigilance at the Medicines Control Agency (MCA) concluded a 3-day Good Clinical Practice (GCP) Inspection at the Medical Research Council, The Gambia (MRCG), London School of Hygiene and Tropical Medicine clinical trials site in Basse, from 24–26 August 2026.

The objective of the inspection is to safeguard the safety, rights, and wellbeing of trial participants by reviewing documentation against approved study protocols, as well as strengthen clinical trials regulation in The Gambia, and supports MCA's progress toward WHO Maturity Level 3, a global benchmark for high-performing medicines regulatory authorities.

MSEC Meets to Strengthen Medicines Safety Oversight The Directorate of Clinical Trials and Pharmacovigilance (DCTPV) of ...
28/08/2026

MSEC Meets to Strengthen Medicines Safety Oversight

The Directorate of Clinical Trials and Pharmacovigilance (DCTPV) of the Medicines Control Agency (MCA) convened a two-day Medicines Safety Expert Committee (MSEC) meeting on 18–19 August 2026 at the MCA Conference Room in Sukuta.

Under the Medicines Regulation Act, 2014, the responsibilities of MSEC includes the provision of technical support for the review of clinical trial applications and for post approval safety and compliance issues; the provision of technical support for Pharmacovigilance (PV) including Causality Assessment and make recommendation/s and/or advise the Executive Director on Clinical Trial and Pharmacovigilance issues. The members of the MSEC comprised of diverse health professionals with expert backgrounds.

The meeting reviewed reports of Serious Adverse Events (SAEs), Adverse Drug Reactions (ADRs), and Adverse Events Following Immunization (AEFIs), giving MSEC members the opportunity to conduct causality assessments and provide expert recommendations to guide MCA's regulatory decision-making in Clinical Trials and Pharmacovigilance.

18/08/2026

The Medicines Prescribed for You Are for You Alone!

Sharing Medicines Could Lead to Serious Health Complications.

Report all Adverse Drug Reactions to nearest health facility or call MCA Qcell toll-free 1233

17/08/2026

The ADR campaign may have ended, but, the message shouldn’t stop here or be ignored.

A message from the community of Sasita Torangka is that one should return to the nearest hospital/ health facility when they experience any unusual side effects from medicines or related products. These maybe skin rashes, itching, swollen face, breathing difficulty etc.

Reporting adverse drug reactions helps MCA and relevant authorities to take appropriate actions to ensure that medicines in the country are of quality, safe and efficacious.

Together we can ensure a healthier Gambia for all.

MCA Commenced External Quality Management System AuditThe Medicines Control Agency (MCA) on 11 August 2026, hosted AFNOR...
12/08/2026

MCA Commenced External Quality Management System Audit

The Medicines Control Agency (MCA) on 11 August 2026, hosted AFNOR as the external Auditor of its Quality Management System (QMS) for an audit exercise ending on Friday, 14 August, 2026.

The audit forms part of the Agency’s continued efforts to maintain its ISO 9001:2015 certification and strengthen the efficiency and effectiveness of its QMS.

The engagements commenced with an opening meeting involving members of the Senior Management Team (SMT), QMS Focal Persons, and the External Auditor from AFNOR. The meeting formally opened the audit exercise and provided an opportunity to review the audit objectives, scope, methodology, and planned activities.

Following the opening meeting, the External Auditor proceeded with the assessment in accordance with the approved audit plan, engaging relevant directorates/departments, reviewing the Agency’s processes, procedures, records, and other relevant documentation.

The audit provides an important opportunity for the Agency to assess the continued effectiveness and conformity of it's QMS, identify opportunities for improvement, and further strengthen the quality and efficiency of the Agency’s operations .

The audit activities will continue in accordance with the agreed audit schedule.

MCA Appears before FPAC of the National Assembly of The GambiaThe Governing Board and Management of the Medicines Contro...
29/07/2026

MCA Appears before FPAC of the National Assembly of The Gambia

The Governing Board and Management of the Medicines Control Agency (MCA) presents for consideration its Annual Activity Reports, Financial Statements and Management Letters for the years 2020-2024 to the Finance and Public Accounts Committee (FPAC) of the National Assembly on Monday and Tuesday, 27–28 July 2026.

This engagement reflects the Agency's continued commitment to transparency, accountability, and full compliance with the relevant Laws of The Gambia governing public institutions.

The Committee members commended the Agency for its compliance as there were no major issues with its reports.

MCA Wraps Up Nationwide Pharmacovigilance Sensitisation Campaign!Today, Friday, 24 July 2026, marks the successful concl...
24/07/2026

MCA Wraps Up Nationwide Pharmacovigilance Sensitisation Campaign!

Today, Friday, 24 July 2026, marks the successful conclusion of The Medicines Control Agency (MCA) Nationwide Pharmacovigilance Sensitisation Campaign.

Launched on 22 June 2026, this month-long initiative aimed to build a culture of medicine safety across The Gambia.

The nationwide campaign closed out in the Western One Health Region with a high-impact engagements with nursing students at the American International University, West Africa.

This is aimed at developing the healthcare workers with the habit
of patient's safety.

For far too long, reporting side effects have been treated passively or even dismissed as standard treatment risks, therefore, MCA wishes to shift that paradigm to regular reporting of side effects in a timely manner.

During today's session, MCA Team took the AIUWA students through:

The foundations of Clinical Trials & Pharmacovigilance History;

Understanding why monitoring exists is because while medicines are designed to cure, every medicinal product carries a potential risk.

Mastering Reporting Protocols, as a
step-by-step demonstration on how to accurately complete Suspected Adverse Drug Reactions (ADRs) and Adverse Events Following Immunization (AEFIs) reporting forms

Integrating proactive risk reporting directly into routine clinical practices is vital to patients' safety.

Why Every Report Matters.

The data gathered from these ADR and AEFI forms directly feeds MCA's national database. Accurate, real-time reporting gives us a clear picture of medicines safety across The Gambia, enabling MCA to make evidence-based policy recommendations and can advise the Ministry of Health on public safety actions.

The AIUWA students expressed deep gratitude to the MCA for expanding their knowledge in Pharmacovigilance and pledged to act as frontline guardians of medicines safety in every health facility they serve.

"Reporting even the mildest side effect today prevents major health risks tomorrow."

Thank you to all healthcare workers, community leaders, students, and regional health teams across The Gambia who made this nationwide campaign a resounding success!

Together, we are building a safer healthcare system.

MCA Empowers Nursing Students at Hadigala International College through its Nationwide Pharmacovigilance Sensitisation. ...
23/07/2026

MCA Empowers Nursing Students at Hadigala International College through its Nationwide Pharmacovigilance Sensitisation.

As part of the Medicines Control Agency (MCA's) ongoing commitment to medicines safety, its Team successfully engaged final-year students at Hadigala International College in Western One Health Region.

"Catching them young" is at the heart of MCA strategy. By equipping nursing students with critical pharmacovigilance skills before they step onto the clinical practices to ensure our healthcare facilities remain safe and proactive.

Understanding the Drug Lifecycle, Students learned how medicines progress from pre-clinical, to clinical trials and finally routine use clincally, but most importantly, why safety monitoring continues even after a medicine is in the market.

The Team highlighted how individual biological differences can cause varying reactions to the same medicine.

Hands-on guidance was provided on correctly identifying and filling out suspected Adverse Drug Reactions (ADRs) and Adverse Events Following Immunisation (AEFIs) reporting forms.

The emphasis on reporting any side effect for its documentation in the national pharmacovigilance system helps in informed decisions towards an improved healthcare system.

The students left inspired and fully equipped to serve as frontline guardians of patients' safety as they prepared to join the healthcare workforce.

Pharmacovigilance is everyone's business. Let's report any side effects.


-NEPAD

MCA Engages Private Health Sector: Jaama Specialty Hospital & Afrimed HospitalThe private healthcare sector plays a vita...
23/07/2026

MCA Engages Private Health Sector: Jaama Specialty Hospital & Afrimed Hospital

The private healthcare sector plays a vital role in service delivery, which is why MCA is engaging Staff of private health facilities to build a strong culture of ADRs reporting.

At Jaama Specialty Hospital, discussions with Staff focused on the importance of reporting Adverse Drug Reactions (ADRs) and medicines defects to ensure patients safety.

Dr. Cathrine Sarr, a Staff member at Jaama, thanked MCA for this valuable initiative, stressing that reporting must be taken seriously to prevent situations like Acute Kidney Injury (AKI) crisis. She also encouraged MCA to train community Pharmacists across The Gambia, since most patients visit a Pharmacy before going to a hospital.

The Team also met with Senior Management and the Pharmacovigilance focal point at Afrimed Hospital, highlighting the need to encourage Nurses and other healthcare providers to strengthen reporting of ADRs and Adverse Events Following Immunization (AEFI).

To date, MCA has trained over 50 Pharmacovigilance focal persons across health facilities nationwide to drive stronger reporting systems.

Follow our journey across communities, health facilities, and schools nationwide as we work toward safer medicines for all.

Every report brings us one step closer to a safer, healthier Gambia.

MCA Strengthening Patient Safety Through Pharmacovigilance Awareness CampaignThe Medicines Control Agency (MCA) Team tod...
22/07/2026

MCA Strengthening Patient Safety Through Pharmacovigilance Awareness Campaign

The Medicines Control Agency (MCA) Team today, Wednesday, 22 July 2026, visited Old Jeshwang and New Jeshwang Health Facilities in the Western One Health Region as part of its ongoing Pharmacovigilance Sensitisation Campaign.

The campaign focused on strengthening the reporting of Adverse Drug Reactions (ADRs) and Adverse Events Following Immunisation (AEFIs) through direct engagement with healthcare providers.

While all approved medicines and vaccines are designed to treat patients, they can occasionally cause side effects.

To maintain a safe healthcare system, it is vital to systematically record and monitor these occurrences.

During the sessions, healthcare workers received hands-on, step-by-step guidance on:

Identifying and documenting suspected ADRs and AEFIs.
Properly completion of the standard ADRs/AEFIs reporting forms.

Engage patients with empathy and active listening when they report any side effects, as this can foster trust between the community and the health system but also enhance the national pharmacovigilance system.

Participating healthcare providers commended the engagement as both timely and highly educational, expressing renewed confidence in documenting and submitting safety reports.

Through continuous sensitisation, MCA aims to build a robust national pharmacovigilance system for public health across the nation.

-NEPAD

Address

Off OIC Harding Highway Sukuta West Coast Region The Gambia, P. O. Box 3162
Sukuta
00220

Opening Hours

Monday 08:30 - 16:00
Tuesday 08:30 - 16:00
Wednesday 08:30 - 16:00
Thursday 08:30 - 16:00
Friday 08:30 - 04:00

Alerts

Be the first to know and let us send you an email when Medicines Control Agency posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share